Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

NCT01715493 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Asthma

Interventions

DRUG: lysozyme 90 mg
DRUG: Placebo

Sponsor

Eisai Co., Ltd.